Spacer length effects on in vitro imaging and surface accessibility of fluorescent inhibitors of prostate specific membrane antigen
about
Prostate-specific membrane antigen as a target for cancer imaging and therapyStructure-Activity Relationship of (18)F-Labeled Phosphoramidate Peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-Targeted Inhibitor Analogues for PET Imaging of Prostate Cancer177Lu-Labeled Phosphoramidate-Based PSMA Inhibitors: The Effect of an Albumin Binder on Biodistribution and Therapeutic Efficacy in Prostate Tumor-Bearing Mice.Development of a high-throughput fluorescence polarization assay to identify novel ligands of glutamate carboxypeptidase IIDevelopment of inhibitor-directed enzyme prodrug therapy (IDEPT) for prostate cancer.Design of composite inhibitors targeting glutamate carboxypeptidase II: the importance of effector functionalitiesTargeting prostate cancer cells with a multivalent PSMA inhibitor-guided streptavidin conjugate.Targeting prostate cancer cells with PSMA inhibitor-guided gold nanoparticles.PSMA PET and Radionuclide Therapy in Prostate Cancer.A high-affinity near-infrared fluorescent probe to target bombesin receptors.Preparation and evaluation of carborane-derived inhibitors of prostate specific membrane antigen (PSMA).Design, synthesis and binding properties of a fluorescent α₉β₁/α₄β₁ integrin antagonist and its application as an in vivo probe for bone marrow haemopoietic stem cells.Spacer length impacts the efficacy of targeted docetaxel conjugates in prostate-specific membrane antigen expressing prostate cancerSingle molecular weight discrete PEG compounds: emerging roles in molecular diagnostics, imaging and therapeutics.PSMA-targeted contrast agents for intraoperative imaging of prostate cancer.
P2860
Q26799439-D1F34937-4CDA-467F-957A-B1D3DE1877B7Q27705945-B71DE51D-2256-4BFD-AD05-C6DEA2C9473CQ33821017-451FB5D2-6DEA-4989-80F6-7ED6CE32A16AQ33957067-EC9C04B3-1A91-4DA0-B89E-6B183BCC9D8FQ34343529-B92F0476-3039-47B2-9DBB-FCD6664F8226Q36460130-F1677DE0-BEF6-4FE2-8722-B767991DCA80Q36477594-73678DE2-74D4-48B4-B13B-09F7753B89DCQ36501550-7080AB33-EFF1-49E6-A9C3-E5D0F939B80FQ39003089-7D6DE703-6E68-4293-BB7F-F679157FD994Q39017820-35BBCA86-EACE-47CC-8E59-83942C0E594EQ39028837-2FB776FA-4079-4052-B48F-87E99FDFCFC7Q39040969-F1D1D9C6-9DCC-46F9-A10A-76B8EE03B62FQ39070519-CE7ED974-127F-48E9-8157-FB09D1066FD8Q42175213-B8D00165-9B0F-47B4-9EA2-1006E49689CCQ47148639-F1873501-0C7A-43F1-859E-6D98C5EFB5E3
P2860
Spacer length effects on in vitro imaging and surface accessibility of fluorescent inhibitors of prostate specific membrane antigen
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Spacer length effects on in vi ...... tate specific membrane antigen
@ast
Spacer length effects on in vi ...... tate specific membrane antigen
@en
type
label
Spacer length effects on in vi ...... tate specific membrane antigen
@ast
Spacer length effects on in vi ...... tate specific membrane antigen
@en
prefLabel
Spacer length effects on in vi ...... tate specific membrane antigen
@ast
Spacer length effects on in vi ...... tate specific membrane antigen
@en
P2093
P2860
P1476
Spacer length effects on in vi ...... tate specific membrane antigen
@en
P2093
Clifford E Berkman
Jessie R Nedrow-Byers
Mark R Hopkins
Tiancheng Liu
P2860
P304
P356
10.1016/J.BMCL.2011.09.115
P407
P577
2011-10-04T00:00:00Z